Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer

  • Yue Chen, Ming Ji, Shen Zhang, Nina Xue, Heng Xu, Songwen Lin, Xiaoguang Chen
  • Journal of Drug Targeting, April 2018, Taylor & Francis
  • DOI: 10.1080/1061186x.2018.1452244

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/1061186x.2018.1452244